Clinical Trials Directory

Trials / Completed

CompletedNCT00990600

QoL and Adherence to One-pill Once-a-day HAART

Adherence to a One Pill, Once-a-day Antiretroviral Regimen

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
212 (actual)
Sponsor
A.O. Ospedale Papa Giovanni XXIII · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Primary objective of the study is: To verify if simplification of the antiretroviral regimen, measured as the reduction of pill burden alone, may affect adherence rate of patients.

Conditions

Interventions

TypeNameDescription
OTHERreduced number of pillsSwitch to a fixed dose combination one pill/daily HAART

Timeline

Start date
2008-04-01
Primary completion
2009-05-01
Completion
2009-05-01
First posted
2009-10-07
Last updated
2009-10-29

Source: ClinicalTrials.gov record NCT00990600. Inclusion in this directory is not an endorsement.